Amlodipin/Valsartan/Hydroklortiazid Teva B.V. 5 mg/ 160 mg/ 25 mg Filmdragerad tablett

Ülke: İsveç

Dil: İsveççe

Kaynak: Läkemedelsverket (Medical Products Agency)

şimdi satın al

Ürün özellikleri Ürün özellikleri (SPC)
16-04-2020

Aktif bileşen:

amlodipinbesilat; hydroklortiazid; valsartan

Mevcut itibaren:

Teva B.V.

ATC kodu:

C09DX01

INN (International Adı):

amlodipinbesilat; hydrochlorothiazide; valsartan

Doz:

5 mg/ 160 mg/ 25 mg

Farmasötik formu:

Filmdragerad tablett

Kompozisyon:

laktosmonohydrat Hjälpämne; valsartan 160 mg Aktiv substans; amlodipinbesilat 6,93 mg Aktiv substans; hydroklortiazid 25 mg Aktiv substans

Reçete türü:

Receptbelagt

Ürün özeti:

Förpacknings: Blister, 14 tabletter; Blister, 28 tabletter; Blister, 30 tabletter; Blister, 56 tabletter; Blister, 90 tabletter; Blister, 98 tabletter; Burk, 100 tabletter

Yetkilendirme durumu:

Avregistrerad

Yetkilendirme tarihi:

2020-04-15

Ürün özellikleri

                                1
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
Amlodipin/Valsartan/Hydroklortiazid Teva B.V. 10 mg/160 mg/12.5 mg
film-coated tablets
Amlodipin/Valsartan/Hydroklortiazid Teva B.V. 5 mg/160 mg/25 mg
film-coated tablets
Amlodipin/Valsartan/Hydroklortiazid Teva B.V. 10 mg/160 mg/25 mg
film-coated tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
[Product name] 10 mg/160 mg/12.5 mg film-coated tablets
Each film-coated tablet contains amlodipine besilate equivalent to 10
mg amlodipine, 160 mg of
valsartan, and 12.5 mg of hydrochlorothiazide.
[Product name] 5 mg/160 mg/25 mg film-coated tablets
Each film-coated tablet containsamlodipine besilate equivalent to 5 mg
amlodipine, 160 mg of
valsartan, and 25 mg of hydrochlorothiazide.
[Product name] 10 mg/160 mg/25 mg film-coated tablets
Each film-coated tablet containsamlodipine besilate equivalent to 10
mg amlodipine, 160 mg of
valsartan, and 25 mg of hydrochlorothiazide.
Excipient(s) with known effect
[Product name] 10 mg/160 mg/12.5 mg film-coated tablets
Each tablet contains 5 mg of lactose.
[Product name] 5 mg/160 mg/25 mg film-coated tablets
Each tablet contains 5 mg of lactose.
[Product name] 10 mg/160 mg/25 mg film-coated tablets
Each tablet contains 5 mg of lactose.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Film-coated tablet (tablet)
[Product name] 10 mg/160 mg/12.5 mg film-coated tablets
Oval, light yellow, 14.5 mm x 7.5 mm film-coated tablets with bevelled
edges, with debossing VIL on
one side of the tablet.
[Product name] 5 mg/160 mg/25 mg film-coated tablets
Oval, yellow, 14.5 mm x 7.5 mm film-coated tablets with bevelled
edges, with debossing VIH on one
side of the tablet
[Product name] 10 mg/160 mg/25 mg film-coated tablets
Oval, dark yellow, 14.5 mm x 7.5 mm film-coated tablets with bevelled
edges, with debossing VIT on
one side of the tablet.
2
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Treatment of essential hypertension as substitution therapy in adult
patients whose blood pressure is
adeq
                                
                                Belgenin tamamını okuyun
                                
                            

Diğer dillerdeki belgeler

Bilgilendirme broşürü Bilgilendirme broşürü İngilizce 16-08-2022
Ürün özellikleri Ürün özellikleri İngilizce 31-08-2020
Kamu Değerlendirme Raporu Kamu Değerlendirme Raporu İngilizce 27-05-2020